Valar Labs
Valar Labs is an AI oncology company building diagnostics that interpret solid tumors from routine pathology slides to predict cancer treatment response. Its proprietary CHAI (Computational Histology Artificial Intelligence) platform analyzes digitized H&E-stained slides — trained on 500,000+ pathologist annotations of tumors and their microenvironment — to help physicians and patients make evidence-based therapy decisions. Products include Vesta Bladder (predicting BCG response in non-muscle-invasive bladder cancer), Vesta Prostate, and Vitara Pancreas ChemoPredict (guiding first-line chemotherapy selection in advanced pancreatic cancer). Founded at the intersection of AI and oncology and backed by a16z and DCVC, Valar Labs delivers results within days without requiring additional tissue. The company operates a physician ordering portal at portal.valarlabs.com and publishes no public developer API, SDK, or machine-readable API specification as of this profile.
Valar Labs is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Oncology, Cancer, and Diagnostics.
Valar Labs’ developer surface includes developer portal, engineering blog, support, and 7 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 1
Portal, sign-up, and the first successful call
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 5
The organization behind the API